Morning Market Movers
Celldex Therapeutics (NASDAQ: CLDX) surged 25.34% to $6.9190 at 9:54 am. Celldex Therapeutics announced final results from the company's randomized Phase 2b EMERGE study of CDX-011 in patients with glycoprotein NMB (GPNMB)-expressing, advanced, heavily pretreated breast cancer.
Guanwei Recycling (NASDAQ: GPRC) climbed 25.15% to $2.09. Guanwei Recycling's trailing-twelve-month ROE is 33.04%.
Geron (NASDAQ: GERN) surged 24.53% to $1.32. Geron reported positive clinical results from the Phase 2 trial of imetelstat in patients with essential thrombocythemia.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.